Explore more publications!
West Virginia Healthcare Press
Got News to Share?

West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 14, 2025

Avicanna Reports Q3 2025
November 14, 2025

Avicanna Reports Q3 2025

Indeterminate GlobeNewswire
Range Impact Reports 3Q 2025 Financial Results
November 14, 2025

Range Impact Reports 3Q 2025 Financial Results

Indeterminate GlobeNewswire
COSCIENS Biopharma Inc. Announces Leadership Change
November 14, 2025

COSCIENS Biopharma Inc. Announces Leadership Change

Indeterminate GlobeNewswire
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy
November 14, 2025

Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy

Indeterminate GlobeNewswire
Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq
November 14, 2025

Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq

Indeterminate GlobeNewswire
Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update
November 14, 2025

Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update

Indeterminate GlobeNewswire
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
November 14, 2025

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results

Indeterminate GlobeNewswire
BiomX Inc. Announces 1-for-19 Reverse Stock Split
November 14, 2025

BiomX Inc. Announces 1-for-19 Reverse Stock Split

Indeterminate GlobeNewswire
Precipio Announces its Q3-2025 Financial Results
November 14, 2025

Precipio Announces its Q3-2025 Financial Results

Indeterminate GlobeNewswire
Health Catalyst to Participate in Upcoming Investor Conferences
November 14, 2025

Health Catalyst to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates
November 14, 2025

Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates

Indeterminate GlobeNewswire
Biogen Completes Acquisition of Alcyone Therapeutics
November 14, 2025

Biogen Completes Acquisition of Alcyone Therapeutics

Indeterminate GlobeNewswire
Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results
November 14, 2025

Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives
November 14, 2025

TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives

Indeterminate GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 14, 2025

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Femasys Announces Third Quarter Financial Results for 2025
November 14, 2025

Femasys Announces Third Quarter Financial Results for 2025

Indeterminate GlobeNewswire
Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
November 14, 2025

Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million

Indeterminate GlobeNewswire
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026
November 14, 2025

Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026

Indeterminate GlobeNewswire
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
November 14, 2025

FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury

Indeterminate GlobeNewswire
Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q
November 14, 2025

Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions